Owlet, Inc. (OWLT) is a publicly traded Healthcare sector company. As of May 21, 2026, OWLT trades at $5.89 with a market cap of $158.93M and a P/E ratio of -2.21. OWLT moved +7.96% today. Year to date, OWLT is -63.86%; over the trailing twelve months it is +19.16%. Its 52-week range spans $2.75 to $16.94. Analyst consensus is strong buy with an average price target of $13.33. Rallies surfaces OWLT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Owlet Forecasts Q1 Revenue of $20.84M and Cuts 2026 Sales Outlook to $127.27M: Owlet Inc is projected to report Q1 revenue of $20.84 million and a loss of $0.13 per share, with full-year sales forecast trimmed to $127.27 million and EPS at -$0.40. Analysts’ average 12-month price target of $14.25 implies 184% upside versus a GF Value benchmark of $3.62 suggesting 28% downside.
| Metric | Value |
|---|---|
| Price | $5.89 |
| Market Cap | $158.93M |
| P/E Ratio | -2.21 |
| EPS | $-2.63 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.94 |
| 52-Week Low | $2.75 |
| Volume | 281 |
| Avg Volume | 0 |
| Revenue (TTM) | $107.06M |
| Net Income | $-46.04M |
| Gross Margin | 50.86% |
4 analysts cover OWLT: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.33.